Google is partnering with DexCom to develop disposable continuous glucose monitoring devices that will be smaller in size and cheaper than today's monitoring options.
DexCom's sensor technology will be paired with a miniature Google platform for building a bandage-size sensor for a series of "next-generation" CGM tools, according to an announcement.
"We're committed to developing new technologies that will help move healthcare from reactive to proactive," Andrew Conrad, head of the life sciences team at Google, said in the announcement. "This collaboration is another step towards expanding monitoring options and making it easier for people with diabetes to proactively manage their health."
The CGM device is just the first collaboration of future products, according to the statement, as the companies say the partnership has the "potential to change the face of diabetes technology forever."
The news comes about a week after Google announced the creation of holding company, Alphabet. The transition could greatly impact Google's healthcare ventures, FierceHealthIT previously reported.
Google currently has many health-related projects under way. Some of those include a contact lense designed to monitor and measure glucose levels in tears, as well as an mHealth wristband for pharma clinical trials and drug tests to provide research teams with real-time data on patient vital signs.
To learn more:
- read the announcement